146 related articles for article (PubMed ID: 21481002)
1. Combining factors on protein and gene level to predict radioresponse in head and neck cancer cell lines.
Farnebo L; Jerhammar F; Ceder R; Grafström RC; Vainikka L; Thunell L; Grénman R; Johansson AC; Roberg K
J Oral Pathol Med; 2011 Nov; 40(10):739-46. PubMed ID: 21481002
[TBL] [Abstract][Full Text] [Related]
2. Proteins and single nucleotide polymorphisms involved in apoptosis, growth control, and DNA repair predict cisplatin sensitivity in head and neck cancer cell lines.
Farnebo L; Jedlinski A; Ansell A; Vainikka L; Thunell LK; Grénman R; Johansson AC; Roberg K
Int J Mol Med; 2009 Oct; 24(4):549-56. PubMed ID: 19724896
[TBL] [Abstract][Full Text] [Related]
3. Number of negative points: a novel method for predicting radiosensitivity in head and neck tumor cell lines.
Farnebo L; Jerhammar F; Vainikka L; Grénman R; Norberg-Spaak L; Roberg K
Oncol Rep; 2008 Aug; 20(2):453-61. PubMed ID: 18636211
[TBL] [Abstract][Full Text] [Related]
4. Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients.
Farnebo L; Tiefenböck K; Ansell A; Thunell LK; Garvin S; Roberg K
Int J Cancer; 2013 Oct; 133(8):1994-2003. PubMed ID: 23564498
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy response in oral squamous carcinoma cell lines: evaluation of apoptotic proteins as prognostic factors.
Roberg K; Jonsson AC; Grénman R; Norberg-Spaak L
Head Neck; 2007 Apr; 29(4):325-34. PubMed ID: 17163470
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the chemosensitivity of head and neck cancer cells based on the diverse function of mutated-p53.
Shinagawa Y; Kawamata H; Omotehara F; Nakashiro K; Hoque MO; Furihata T; Horiuchi H; Imai Y; Fujimori T; Fujibayashi T
Int J Oncol; 2003 Feb; 22(2):383-9. PubMed ID: 12527938
[TBL] [Abstract][Full Text] [Related]
7. Candidate apoptotic and DNA repair gene approach confirms involvement of ERCC1, ERCC5, TP53 and MDM2 in radiation-induced toxicity in head and neck cancer.
Borchiellini D; Etienne-Grimaldi MC; Bensadoun RJ; Benezery K; Dassonville O; Poissonnet G; Llorca L; Ebran N; Formento P; Château Y; Thariat J; Milano G
Oral Oncol; 2017 Apr; 67():70-76. PubMed ID: 28351583
[TBL] [Abstract][Full Text] [Related]
8. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
9. Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death.
Frederick MJ; Holton PR; Hudson M; Wang M; Clayman GL
Clin Cancer Res; 1999 Feb; 5(2):361-9. PubMed ID: 10037186
[TBL] [Abstract][Full Text] [Related]
10. Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma.
Hoffmann TK; Sonkoly E; Hauser U; van Lierop A; Whiteside TL; Klussmann JP; Hafner D; Schuler P; Friebe-Hoffmann U; Scheckenbach K; Erjala K; Grénman R; Schipper J; Bier H; Balz V
Oral Oncol; 2008 Dec; 44(12):1100-9. PubMed ID: 18487078
[TBL] [Abstract][Full Text] [Related]
11. Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer.
Pratesi N; Mangoni M; Mancini I; Paiar F; Simi L; Livi L; Cassani S; Buglione M; Grisanti S; Almici C; Polli C; Saieva C; Magrini SM; Biti G; Pazzagli M; Orlando C
Radiother Oncol; 2011 Jun; 99(3):356-61. PubMed ID: 21704413
[TBL] [Abstract][Full Text] [Related]
12. Eradication of p53-mutated head and neck squamous cell carcinoma xenografts using nonviral p53 gene therapy and photochemical internalization.
Ndoye A; Dolivet G; Høgset A; Leroux A; Fifre A; Erbacher P; Berg K; Behr JP; Guillemin F; Merlin JL
Mol Ther; 2006 Jun; 13(6):1156-62. PubMed ID: 16564229
[TBL] [Abstract][Full Text] [Related]
13. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
Crowe DL; Sinha UK
Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
[TBL] [Abstract][Full Text] [Related]
14. Targeting apoptosis to overcome cisplatin resistance: a translational study in head and neck cancer.
Bauer JA; Kumar B; Cordell KG; Prince ME; Tran HH; Wolf GT; Chepeha DB; Teknos TN; Wang S; Eisbruch A; Tsien CI; Urba SG; Worden FP; Lee J; Griffith KA; Taylor JM; D'Silva N; Wang SJ; Wolter KG; Henson B; Fisher SG; Carey TE; Bradford CR
Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S106-8. PubMed ID: 17848273
[TBL] [Abstract][Full Text] [Related]
15. The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells.
Sung ES; Park KJ; Choi HJ; Kim CH; Kim YS
Exp Cell Res; 2012 Aug; 318(13):1564-76. PubMed ID: 22513214
[TBL] [Abstract][Full Text] [Related]
16. A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas.
Lee TL; Yeh J; Friedman J; Yan B; Yang X; Yeh NT; Van Waes C; Chen Z
Int J Cancer; 2008 May; 122(9):1987-98. PubMed ID: 18172861
[TBL] [Abstract][Full Text] [Related]
17. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers.
Sharma H; Sen S; Mathur M; Bahadur S; Singh N
Head Neck; 2004 Aug; 26(8):733-40. PubMed ID: 15287041
[TBL] [Abstract][Full Text] [Related]
18. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
[TBL] [Abstract][Full Text] [Related]
19. EGFR status and EGFR ligand expression influence the treatment response of head and neck cancer cell lines.
Jedlinski A; Ansell A; Johansson AC; Roberg K
J Oral Pathol Med; 2013 Jan; 42(1):26-36. PubMed ID: 22643066
[TBL] [Abstract][Full Text] [Related]
20. The bcl-2 gene status of human head and neck cancer cell lines.
Salo A; Servomaa K; Kiuru A; Pulkkinen J; Grénman R; Pekkola-Heino K; Rytömaa T
Acta Otolaryngol Suppl; 1997; 529():233-6. PubMed ID: 9288319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
